Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
0.0346
-0.0003 (-0.86%)
At close: Jan 31, 2025, 4:00 PM
0.0350
+0.0004 (1.16%)
After-hours: Jan 31, 2025, 7:47 PM EST
Eyenovia Employees
Eyenovia had 57 employees as of December 31, 2023. The number of employees increased by 16 or 39.02% compared to the previous year.
Employees
57
Change (1Y)
16
Growth (1Y)
39.02%
Revenue / Employee
$558
Profits / Employee
-$663,698
Market Cap
3.86M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
EYEN News
- 4 days ago - Eyenovia Announces 1-for-80 Reverse Stock Split - GlobeNewsWire
- 17 days ago - Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - GlobeNewsWire
- 26 days ago - Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewsWire
- 2 months ago - Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - GlobeNewsWire
- 2 months ago - Eyenovia Provides Update on Restructuring Efforts - GlobeNewsWire
- 2 months ago - Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline - Benzinga
- 2 months ago - Eyenovia to discontinue late-stage study for eye drug - Reuters
- 2 months ago - Eyenovia Provides Update on Phase 3 CHAPERONE Study - GlobeNewsWire